
Samrat Pharmachem Ltd.
251.00+0.0 (+0.00%)
27 Jul, 2:59 PM
Annual Reports and Financial Documents
Samrat Pharmachem Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Samrat Pharmachem Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Board Meeting Intimation for Notice Of Board Meeting For Un-Audited Financial Results For The Quarter Ended June 30, 2026Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Approval of Un-Audited Financial ....
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A7 Apr 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
- Board Meeting Intimation for Audited Financial Results For The Financial Year Ended March 31, 2026Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....
- Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31, 2025Samrat Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the un-audited financial ....
Frequently Asked Questions
Where can I download the annual report of Samrat Pharmachem Ltd.?
Annual reports of Samrat Pharmachem Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Samrat Pharmachem Ltd.?
Quarterly earnings results and presentations of Samrat Pharmachem Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Samrat Pharmachem Ltd. publish earnings call transcripts?
Earnings call transcripts of Samrat Pharmachem Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Samrat Pharmachem Ltd.?
Investor presentations and annual day presentations of Samrat Pharmachem Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Samrat Pharmachem Ltd.?
Corporate announcements and regulatory filings of Samrat Pharmachem Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Samrat Pharmachem Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Samrat Pharmachem Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Samrat Pharmachem Ltd.?
The ISIN (International Securities Identification Number) of Samrat Pharmachem Ltd. is INE103E01016. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Samrat Pharmachem Ltd. listed?
Samrat Pharmachem Ltd. is listed on NSE and BSE. The NSE symbol is 530125-BOM and the BSE code is -.
Where can I find the shareholding pattern of Samrat Pharmachem Ltd.?
The quarterly shareholding pattern of Samrat Pharmachem Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Samrat Pharmachem Ltd. on Sharpely?
Share price data for Samrat Pharmachem Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.